WHAT THE STUDY ACTUALLY SAYS

Does sunscreen prevent wrinkles? A four-and-a-half-year trial says yes

In the one randomised trial to test it, adults who used sunscreen daily showed no detectable increase in skin ageing over 4.5 years — 24% less than those who used it as they pleased.

Daily sunscreen does appear to slow the wrinkling, sagging and blotching that people mean by "ageing" skin — not just skin cancer. In the only randomised trial built to test that specific question, middle-aged adults who applied sunscreen every day showed no detectable increase in skin ageing over four and a half years, and 24% less ageing than a group told to use it at their own discretion [s1].

The one trial that tested it

Most of what gets said about sunscreen and wrinkles is inference from the fact that ultraviolet light damages skin. The direct evidence rests largely on a single study run in Nambour, in subtropical Queensland, Australia [s1]. Researchers randomly assigned 903 adults younger than 55, drawn from 1,621 people on a community register, into four groups: daily broad-spectrum sunscreen with a 30 mg β-carotene supplement, daily sunscreen with placebo, discretionary sunscreen with 30 mg β-carotene, and discretionary sunscreen with placebo [s1]. Skin ageing was measured by grading the fine surface pattern — the microtopography — of the back of the hand between 1992 and 1996, by assessors who did not know which group anyone was in [s1].

The daily-sunscreen group showed no detectable increase in skin ageing across the 4.5 years [s1]. Compared with the discretionary group, skin ageing from start to finish was 24% lower, a relative odds of 0.76 with a 95% confidence interval of 0.59 to 0.98 — an effect that just clears statistical significance [s1]. The β-carotene supplement had no overall effect on ageing either way [s1]. The trial was funded by Australia's National Health and Medical Research Council, not by a sunscreen manufacturer [s1].

That combination is what makes the result unusually clean for a cosmetic claim: a randomised design, blinded grading, a real-world duration, and independent funding. It is also, still, one trial in one fair-skinned population at high sun exposure, and the authors noted that some outcome data were missing and the power to detect moderate effects was modest [s1].

Why the direction is not surprising

The trial fits a larger body of observational work showing that sun exposure, specifically, drives the visible signs people try to treat. In a study of 298 Caucasian women aged 30 to 78, split by a dermatologist into 157 sun-seekers and 141 sun-avoiders on the basis of their exposure history, the sun-seeking group carried markedly more wrinkling, sagging and uneven pigmentation for their age [s2]. That is association, not proof — but it points the same way as the Nambour trial, and the mechanism, ultraviolet damage to collagen and elastin, is well established [s2].

This is the distinction the marketing tends to blur. "Anti-ageing" on a moisturiser usually refers to ingredients applied to skin that is already ageing; the sunscreen evidence is about preventing the damage in the first place. The prevention case is the stronger one.

What it does not settle

The Nambour result does not tell a buyer that a higher SPF number, or a pricier bottle, buys proportionally younger skin — the trial compared daily use against as-needed use, not one product against another [s1]. It also cannot separate the protection from all the other things sun-avoidant people do. And the outcome was a surface-texture grade, a stand-in for ageing rather than a direct count of wrinkles [s1].

The regulatory guidance stays deliberately plain. The US Food and Drug Administration lists early skin ageing among the harms that sun protection reduces, and advises broad-spectrum sunscreens of SPF 15 or higher, used regularly and reapplied at least every two hours, alongside shade and clothing [s3]. Sunscreen is not framed as a cosmetic upgrade there; it is one layer of sun protection, and the ageing benefit rides along with the cancer one.

The honest summary is that this is one of the few "anti-ageing" claims with a randomised trial behind it, that the trial found a real but modest effect, and that daily and consistent use — not the SPF on the label — is the part the evidence actually supports [s1][s3].

This article is informational and is not medical advice.

Sources

Sources

  1. Sunscreen and prevention of skin aging: a randomized trial — Annals of Internal Medicine , June 4, 2013
  2. Effect of the sun on visible clinical signs of aging in Caucasian skin — Clinical, Cosmetic and Investigational Dermatology , September 27, 2013
  3. Sunscreen: How to Help Protect Your Skin from the Sun — US Food and Drug Administration , June 9, 2026

More on

Related coverage